Bridgefront Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bridgefront Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,987	Closed	-$371K	–	465
2021 Q4	$371K	Buy	+3,987	New	+$263K	0.36%	94

Bridgefront Capital's ARNA Position: Q1 2022 in Review

Bridgefront Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,987 shares — an estimated $371K sold.

Bridgefront Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $371K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Bridgefront Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Bridgefront Capital sold 3,987 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $371K.
Bridgefront Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Bridgefront Capital's Arena Pharmaceuticals Inc position peaked at $371K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bridgefront Capital's 13F filing for Q1 2022, filed 13 May 2022.